Literature DB >> 16426035

Developing an antituberculosis compounds database and data mining in the search of a motif responsible for the activity of a diverse class of antituberculosis agents.

Om Prakash1, Indira Ghosh.   

Abstract

A novel data mining procedure to look for new antitubercular agents and targets as well as to find a minimum common bioactive substructure (MCBS), has been reported here. The methodology extracts MCBS, both across the diverse chemical classes and within the particular chemical class, known to be present in the various marketed drugs alongside antimycobacterial compounds with known MICs. For this purpose a small in-house database of compounds has been created, for which MICs against Mycobacterium are known. The compounds have been collected from literature available on the synthetic compounds, having known MICs against Mycobacterium tuberculosis. An elaborate HQSAR (Hologram QSAR) study has been attempted to extract active fragment from a diverse class of compounds, in combination with the clustering technique to select a homogeneous group of compounds having good a profile toward the activity. The 2D pharmacophore (the 2D fragments extracted from HQSAR) has been validated searching the database. It has been found further that this validated 2D pharmacophore could be used for searching the orphan target in Mycobacterium effectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16426035     DOI: 10.1021/ci050115s

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  7 in total

Review 1.  Fragment-based QSAR: perspectives in drug design.

Authors:  Lívia B Salum; Adriano D Andricopulo
Journal:  Mol Divers       Date:  2009-01-31       Impact factor: 2.943

Review 2.  Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery.

Authors:  Sean Ekins; Joel S Freundlich; Inhee Choi; Malabika Sarker; Carolyn Talcott
Journal:  Trends Microbiol       Date:  2010-12-02       Impact factor: 17.079

Review 3.  Recent advances in fragment-based QSAR and multi-dimensional QSAR methods.

Authors:  Kyaw Zeyar Myint; Xiang-Qun Xie
Journal:  Int J Mol Sci       Date:  2010-10-08       Impact factor: 5.923

4.  Bigger data, collaborative tools and the future of predictive drug discovery.

Authors:  Sean Ekins; Alex M Clark; S Joshua Swamidass; Nadia Litterman; Antony J Williams
Journal:  J Comput Aided Mol Des       Date:  2014-06-19       Impact factor: 3.686

5.  Fusing dual-event data sets for Mycobacterium tuberculosis machine learning models and their evaluation.

Authors:  Sean Ekins; Joel S Freundlich; Robert C Reynolds
Journal:  J Chem Inf Model       Date:  2013-10-30       Impact factor: 4.956

6.  Collaborative development of predictive toxicology applications.

Authors:  Barry Hardy; Nicki Douglas; Christoph Helma; Micha Rautenberg; Nina Jeliazkova; Vedrin Jeliazkov; Ivelina Nikolova; Romualdo Benigni; Olga Tcheremenskaia; Stefan Kramer; Tobias Girschick; Fabian Buchwald; Joerg Wicker; Andreas Karwath; Martin Gütlein; Andreas Maunz; Haralambos Sarimveis; Georgia Melagraki; Antreas Afantitis; Pantelis Sopasakis; David Gallagher; Vladimir Poroikov; Dmitry Filimonov; Alexey Zakharov; Alexey Lagunin; Tatyana Gloriozova; Sergey Novikov; Natalia Skvortsova; Dmitry Druzhilovsky; Sunil Chawla; Indira Ghosh; Surajit Ray; Hitesh Patel; Sylvia Escher
Journal:  J Cheminform       Date:  2010-08-31       Impact factor: 5.514

Review 7.  Early Drug Development and Evaluation of Putative Antitubercular Compounds in the -Omics Era.

Authors:  Alina Minias; Lidia Żukowska; Ewelina Lechowicz; Filip Gąsior; Agnieszka Knast; Sabina Podlewska; Daria Zygała; Jarosław Dziadek
Journal:  Front Microbiol       Date:  2021-02-02       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.